Email this article 
Patients’ experiences with cognitive changes after chemotherapy
Abstract
Being diagnosed with cancer and undergoing treatment can be a daunting experience. The side effects of treatment often influence a person’s quality of life. One side effect that has been identified more recently is known as “chemobrain.” Although attempts have been made to quantify and measure cognitive changes, little attention has been paid to describing the changes from the patient’s viewpoint.
Full Text:
PDFReferences
Anderson-Hanley, C., Sherman, M.L., Riggs, R., Agocha, V.B., &
Compas, B.E. (2003). Neutropsychological effects of treatments for
adults with cancer: A meta-analysis and review of the literature.
Journal of International Neuropsychology, Soc 9, 967.
Ahles, T., Saykin, A., Charlotte, F., Cole, B., Mott, L., Skalla, K., et
al. (2002). Neuropsychologic impact of standard-dose systemic
chemotherapy in long-term survivors of breast cancer and
lymphoma. Journal of Clinical Oncology, 20(2), 485–493.
Bender, C., Paraska, K., Sereika, S., Ryan, C., & Berga, S. (2001).
Cognitive function and reproductive hormones in adjuvant therapy
for breast cancer: A critical review. Journal of Pain and
Symptom Management, 21(5), 407–424.
Brezden, C., Phillips, K., Abdolell, M., Bunston, T., & Tannock, I.
(2000). Cognitive function in breast cancer patients receiving
adjuvant chemotherapy. Journal of Clinical Oncology, 18(14),
–2701.
Correa, D.D., DeAngelis, L.M., Shi, W., Thaler, H., Glass, A., &
Abrey, L.E. (2004). Cognitive function in survivors of primary
central nervous system lymphoma. Neurology, 62, 548–55.
Fitch, M.I. (2000). Supportive care for cancer patients. Hospital
Quarterly, 3(4), 39–46.
Harden, J.F., Schafenacker, A., Northouse, L., Mood, D., Smith, D.,
Pienta, K., et al. (2002). Couples’ experiences with prostate cancer:
Focus group research. Oncology Nursing Forum, 29(4), 701–709.
Jansen, C.E., Miaskowski, C., Dodd, M., & Dowling, G. (2005).
Chemotherapy-induced cognitive impairment in women with
breast cancer: A critique of the literature. Oncology Nursing
Forum, 5(32), 329–342.
Johnson, C. (2006, January 20). Fatigue causes “chemo-brain” in
women. Medical Post, Toronto, 42, Issue 1, p. 15.
Minisini, A., Atalay, G., Bottomley, A., Puglisi, F., Piccarte, M., &
Biganzoli, L. (2004). What is the effect of systemic anticancer
treatment on cognitive function. Lancet Oncology, 5, 273.
Raffa, R.B., Duong, D.V., Finney, J., Garber, D.A., Lam, L.M.
Matthew, S.S., et al. (2006). Is “chemo-fog”/”chemo-brain”
caused by cancer chemotherapy? Journal of Clinical Pharmacy
& Therapeutics 31, 129–138.
Schagen, S., van Dam, F., Muller, M., Boogerd, W., Lindeboom, J.,
& Bruning, P. (1999). Cognitive deficits after postoperative
adjuvant chemotherapy for breast carcinoma. Cancer, 85(3),
–650.
Schilling, Z., Jenkins, V., & Trapala, I.S. (2006). The
(mis)classification of chemo-fog—Methodological inconsistencies
in the investigation of cognitive impairment after chemotherapy.
Breast Cancer Research & Treatment, 95, 125–129.
Speziale, H.S., & Carpenter, D.R. (1999). Qualitative Research in
Nursing: Advancing the Humanistic Imperative. Philadelphia:
Lippincott.
Tannock, I.F., Ahles, T.A., Ganz, P.A., & van Dam, F.S. (2004).
Cognitive impairment associated with chemotherapy for cancer:
Report of a workshop. Journal of Clinical Oncology, 22, 2233.
Tchen, N., Juffs, H., Downie, F., Yi, Q., Hu, H., Chemerynsky, I., et
al. (2003). Cognitive function, fatigue, and menopausal symptoms
in women receiving adjuvant chemotherapy for breast cancer.
Journal of Clinical Oncology, 21(22), 4175–4183.
van Dam, F., Schagen, S., Muller, M., Boogerd, W., Wall, E.,
Droogleever Fortuyn, M., et al. (1998). Impairment of cognitive
function in women receiving adjuvant treatment for high-risk
breast cancer: High dose versus standard dose chemotherapy.
Journal of the National Cancer Institute, 90(3), 210–218.
Wefel, J., Lenzi, R., Theriault, R., Buzdar, A., Cruickshank, S., &
Meyers, C. (2004). Chemobrain in breast carcinoma? A prologue.
Cancer, 101(3), 466–475.
Wieneke, M., & Dienst, E. (1995). Neuropsychological assessment of
cognitive functioning following chemotherapy for breast cancer.
Psycho-Oncology, 4, 61–66.
Refbacks
- There are currently no refbacks.
